ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A


on the basis of reduction of the ceiling prices of bulk drugs, the National Pharmaceutical Pricing Authority (NPPA) in its first significant action has certainly scored brownie points; but just how much of an impact will this have on the overall and sharply rising public/private expenditure on medicines and therefore on health care?

Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

826for India

$50for overseas users

Get instant access to the complete EPW archives

Subscribe now


(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top